CAR-T Cell Therapy (BeOne Medicines)

N/A

Report date: 2026/05/15 20:01:45

Base Information

Drug NameCAR-T Cell Therapy (BeOne Medicines)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionT lymphocyte replacements

TargetsNot applicable

Therapy Area/IndicationsLymphoma, Mantle-Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesBeOne Medicines Ltd

China Registration ClassN/A

Develop Information

Active CompaniesBeOne Medicines Ltd

Inactive CompaniesN/A

Active IndicationsLymphoma, Mantle-Cell

Inactive IndicationsN/A

Other Information

ATC CodeN/A